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Chromosomal instability is a hallmark of cancer, but mitotic regulators are rarely mutated in tumors. Mutations in
the condensin complexes, which restructure chromosomes to facilitate segregation during mitosis, are significantly
enriched in cancer genomes, but experimental evidence implicating condensin dysfunction in tumorigenesis is
lacking. We report that mice inheriting missense mutations in a condensin II subunit (Caph2nes) develop T-cell
lymphoma.Before tumorsdevelop,wefoundthatthesameCaph2mutation impairsploidymaintenancetoadifferent
extent in different hematopoietic cell types, with ploidymost severely perturbed at the CD4+CD8+ T-cell stage from
whichtumors initiate.PremalignantCD4+CD8+Tcells showpersistentcatenationsduringchromosomesegregation,
triggeringDNAdamage indiploiddaughtercells andelevatedploidy.Genomesequencing revealed thatCaph2 single-
mutant tumors are near diploid but carry deletions spanning tumor suppressor genes, whereas P53 inactivation al-
lowedCaph2mutant cells with whole-chromosome gains and structural rearrangements to form highly aggressive
disease. Together, our data challenge the view that mitotic chromosome formation is an invariant process during
development and provide evidence that defective mitotic chromosome structure can promote tumorigenesis.
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Genome integrity is maintained by molecular machines
that drive the duplication and segregation of the genome
and by checkpoints that monitor for incorrect execution
of these processes. As cells enter mitosis, chromosomes
undergo profound structural changes, which are driven
by topoisomerase II and condensins (Swedlow and Hirano
2003). This process removes catenations between sister
chromatids, generates stiff rod-like structures that are
competent for chromosome segregation, and is essential
for genome propagation through the cell cycle in all
eukaryotes.
Condensins belong to the structural maintenance of
chromosomes (SMC) complex family that also includes
cohesin and SMC5/6. In eukaryotes, each SMC complex
contains a heterodimer of SMC ATPase subunits, a single
kleisin subunit, and additional accessory factors (Fig 1A;
Losada and Hirano 2005; Nasmyth and Haering 2005).
Within cohesin and condensin complexes, the C and N
termini of kleisin interact with apposing SMC subunits
to form a tripartite, asymmetric ring-like structure that
can entrap DNA (Gruber et al. 2003; Onn et al. 2007; Na-
smyth and Oliveira 2010; Cuylen et al. 2011; Piazza et al.
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2014). This mode of association has been proposed to al-
low SMCcomplexes to form topological linkages between
chromosomes or different regions on the same DNA
molecule.
Metazoan genomes encode at least two distinct conden-
sin complexes (Ono et al. 2003), which play nonredundant
and incompletely understood roles in the regulation of
chromosome architecture (Ono et al. 2003; Green et al.
2012; Hirano 2012; Nishide and Hirano 2014; Houlard
et al. 2015). Condensin I gains access to chromosomes be-
tween prometaphase and telophase, whereas condensin II
is present in both the nucleus and cytoplasm during inter-
phase and becomes concentrated on chromosome axes
and centromeres during prophase (Hirota et al. 2004;
Ono et al. 2004). Loss of condensin I results in shorter wid-
ermitotic chromosomes, whereas loss of condensin II pro-
duces long chromosomes with reduced axial rigidity (Ono
et al. 2003; Shintomi and Hirano 2011; Green et al. 2012).
Chromosome structure and mitotic fidelity are com-
promised in many cancers, which leads to numerical
and structural chromosome abnormalities and DNA
damage. The underlying causes of abnormal mitosis in
cancer are not well understood, and it is notable that mu-
tations in known mitotic regulators do not occur at high
frequency in cancer genomes. However, successful mito-
sis requires the concerted activity of hundreds of genes
(Neumann et al. 2010). Biologically significant mutations
could therefore be distributed across a large number of
loci at relatively low frequency per gene. Evidence sup-
porting this hypothesis recently arose from a gene net-
work-based analysis of The Cancer Genome Atlas
(TCGA) data set (Leiserson et al. 2015). With the excep-
tion of SMC4, mutations in condensin subunits were
not statistically enriched in tumor genomes when consid-
ered individually; however, statistical significance was
reached when subunits were considered together as a
Figure 1. Missense mutations in Caph2 induce thymic lymphoma. (A) Schematic of the condensin II complex (Bürmann et al. 2013;
Piazza et al. 2014). The box indicates the region that is expanded in B. (B, right) Three-dimensional structure of the Smc head domain
(SmcHead) and ScpAN-terminal domain (ScpAN) fromBacillus subtilis (ProteinData Bank ID3ZGX) (Bürmann et al. 2013) is shownusing
PyMOL.The twononcontiguous sequence regions that together form the SmcATPase head domain are color-coded in orange (SmcHeadN)
and green (SmcHeadC), respectively,while the ScpANdomain fragment is shown in pink. (Left) The side chain of the I15 equivalent residue
in B. subtilis ScpA (I22) and its interacting residues is depicted in sphere representation. Note that residues Y44 andM48 form part of the
second α helix, which makes direct contact with the SMC coiled coil. (C ) Kaplan-Meier plot showing survival of Caph2nes/nes and P53−/−
mutant animals. The study was terminated at 15 mo, and surviving animals were examined for tumors during necropsy. (D) Flow cytom-
etry dot plots show the distribution of thymicT-cell subsets according toCD4 andCD8 expression in tissue fromyoung adultmice (±SEM;
n = 5) and in representative terminal thymic lymphomas.
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single functional entity, reflecting their concerted activi-
ty in the cell.
Previous mouse models of condensin deficiency have
focused primarily on loss-of-function mutations (Smith
et al. 2004; Nishide and Hirano 2014; Houlard et al.
2015), which cause chromosome segregation failure fol-
lowed by cellular and organismal lethality. However, the
majority of condensin mutations in TCGA are missense
and are likely to exert sublethal effects on chromosome
structure. To directly assess the consequences of hypo-
morphic condensin II deficiency on development and
disease, we studied a viable mouse model carrying a con-
stitutive missense mutation in the condensin II kleisin-β
subunit Caph2 (Caph2nes). These mice were reported pre-
viously to exhibit a block during T-cell development, re-
sulting in thymic hypoplasia and reduced numbers of
circulating T cells (Gosling et al. 2007). During T-cell dif-
ferentiation inwild-typemice, the earliest thymic progen-
itors do not express T-cell receptor (TCR) and are double
negative (DN) for CD4 and CD8. Successful VDJ recombi-
nation at the TCRβ chain locus leads to progression
through the β-selection checkpoint and rapid prolifera-
tion, during which cells up-regulate CD4 and CD8 to be-
come double positive (DP). These rapidly proliferating
early DP cells express the transferrin receptor CD71
(DP CD71+), but this marker is down-regulated upon cell
cycle exit (DP CD71−) (Brekelmans et al. 1994), when re-
arrangement of the TCRα chain locus is completed. In
Caph2nes/nes mice, T-cell development is blocked at the
transition fromDN toDP (Gosling et al. 2007), but the cel-
lular defects and their consequences during aging have not
been characterized. We found that Caph2nes/nes mice
develop thymic lymphomas with high penetrance and
then identified the cell of origin and characterized the
cytological and genomic abnormalities that drive con-
densin II-dependent tumor formation. Our data provide
direct experimental evidence that perturbation of the mi-
totic chromosome condensation apparatus can promote
tumorigenesis.
Results
Caph2mutation causes thymic lymphoma
TheCaph2nes allele (I15N) replaces an evolutionarily con-
served hydrophobic amino acid for a polar residue in theN
terminus of Caph2 (Supplemental Fig. S1A). Based on
available crystal structures (Bürmann et al. 2013; Kamada
et al. 2013), the equivalent residue (I22) in prokaryotic
condensins is largely buried and positioned within the
first α helix of the kleisin subunit (ScpA) (Fig. 1A,B). As re-
ported previously (Gosling et al. 2007), the thymuses and
spleens of young Caph2nes/nes adults showed a marked re-
duction in T lymphocytes. Although Caph2nes/nes mice
had lower body weight and reduced brain size compared
with littermate controls (Martin et al. 2016), the develop-
ment of lymphoid organs was disproportionately affected
(Supplemental Fig. S1B).
To determine whether sublethal condensin II pertur-
bation predisposes to cancer, a cohort of Caph2nes/nes
mice was aged for 15 mo. Necropsy revealed lymphoma
in nine of nine aged individuals compared with zero of
eight controls (Fisher’s exact, P < 1 × 10−4) (Fig. 1C). Oth-
er than a single case of leiomyosarcoma in a Caph2nes/nes
animal with concurrent lymphoma, no other tumors
were identified upon necropsy. More than half of the
Caph2nes/nes cohort became terminally ill within the
15-mo study period (log rank, P < 0.02) (Fig. 1C). Lym-
phoma cells typically took over the thymus, spleen,
and lymph nodes and infiltrated the lungs, kidneys,
and liver (Supplemental Fig. S1B; data not shown). Lym-
phoma cells were either CD4+CD8+ DP or CD4loCD8+
(Fig. 1D), revealing their origin from thymic T progenitor
cells that had progressed through the TCRβ selection
checkpoint.
The cell cycles following thymic β selection are known
to be particularly vulnerable to genomic instability
because the most rapid spontaneous tumors to develop
in P53-null mice are lymphomas with a CD4+CD8+ and
immature CD4loCD8+ immunophenotype (Donehower
et al. 1992; Jacks et al. 1994). To assess the role of P53 dur-
ing Caph2-dependent lymphomagenesis, Caph2nes/nes;
P53−/− double-homozygous mutants (referred to here as
“double mutants”) were derived by intercrossing
Caph2nes/nes; P53+/− parents.Double mutants were recov-
ered at approximately Mendelian ratios (19% at weaning;
n = 121; Fisher’s exact, P = 0.35).
To monitor the early stages of tumor development, we
made use of the fact that each T cell undergoing β selec-
tion carries a unique rearrangement at the TCRβ locus.
This can be used as a molecular barcode to quantify clon-
al expansion, where the proportion of identical V-D-J se-
quences detectable in genomic DNA from the thymus
should increase (Supplemental Material; Dudgeon et al.
2014). Such increases can be detected by deep sequencing
of PCR amplicons spanning the variable to constant re-
gions of the TCRβ locus (Dudgeon et al. 2014). At 3-wk
post-partum, the highest proportion of replicated T-cell
clones in the thymus of wild-type, Caph2nes/nes, or
P53−/− single-mutant animals ranged from 0.05% to
0.19%, indicating that no substantial clonal expansion
had occurred by this stage (Fig. 2). In contrast, the thy-
mus of double-mutant animals already contained several
expanded clones by 3-wk post-partum, with four or five
distinct clones each comprising >1% of total sequence
reads, and at least one clone accounting for >20% of
the TCRβ rearrangements detected (Fig. 2). Clonal expan-
sion in P53−/− single-mutant animals is first detectable at
9-wk post-partum (Dudgeon et al. 2014); hence, Caph2
mutation greatly accelerates the outgrowth of clonal T-
cell populations in the thymuses of juvenile P53−/−
animals.
An aging cohort of 14 doublemutants all became termi-
nally ill within 100 d (median survival 81 d) (Fig. 1C), with
massive thymic lymphoma apparent in every case. This
represents a substantially reduced survival relative to ei-
ther mutation alone (median 447 d for Caph2nes/nes; 144
d for P53−/−; Log rank P < 0.001 for both comparisons)
(Fig. 1C). No evidence of nonlymphoid tumors was ob-
served upon necropsy of double-mutant animals.
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Abnormal metaphase chromosome structure
and anaphase in Caph2nes/nes thymocytes
It has been reported previously that thymic T-cell devel-
opment is impaired during the DN-to-DP transition in
young adult Caph2nes/nes individuals (Gosling et al.
2007), which is also the stage duringwhich our data reveal
that lymphomas arise in aged animals (Fig. 1D). The cellu-
lar defects that block T-cell development in Caph2nes/nes
animals are known to be T-cell-autonomous and indepen-
dent of VDJ recombination (Gosling et al. 2007), but it is
not known whether they affect mitosis or possible alter-
native functions of condensin II during interphase (Gos-
ling et al. 2007; Rawlings et al. 2010; Wood et al. 2010).
Althoughwe found that interphase cells at the DP stage
were increased in size inCaph2nes/nes animals, thiswas at-
tributable to increased ploidy rather than interphase chro-
mosome decompaction because no difference in size was
apparent between wild-type and mutant cells of equiva-
lent DNA content (Supplemental Fig. S2A). No evidence
for localized chromatin decondensation was observed in
analyses of mean squared distances (d2) between fluores-
cence in situ hybridization (FISH) probes (Eskeland et al.
2010) separated by 0.1 Mb at the nonexpressed HoxA lo-
cus (Supplemental Fig. S2B) or 0.1, 1, and 5 Mb at the ex-
pressed CD8 locus (Supplemental Fig. S2C) in DP CD71+
Caph2nes/nes cells. Radial positioning (Supplemental Fig.
S2D) and chromocenter clustering (J Woodward, unpubl.)
were also not significantly affected by Caph2mutation.
Expression microarray comparisons between DP thy-
mocyte subsets from Caph2+/+ and Caph2nes/nes animals
revealed only subtle effects on the transcriptome (R2 =
0.99), as expected for comparisons between carefully
stage-matched cell populations (Supplemental Fig. S3A).
However, gene ontology enrichment analysis performed
on gene lists ranked by fold change revealed functional
classifiers that were strongly enriched among genes up-
regulated in Caph2nes/nes cells (Supplemental Fig. S3). In
both the rapidly cycling CD71+ and the quiescent
CD71− DP population, the most significantly enriched
terms centered on metabolism and proteostasis (Supple-
mental Fig. S3B,C; Supplemental Tables S1 and S2).
Each of these processes has recently been implicated in
the cellular stress response to aneuploidy (Torres et al.
2007; Williams et al. 2008; Sheltzer et al. 2012). Thus, al-
though a tumor-causing mutation in Caph2 influences
the size and transcriptional profile of premalignant
cells, both differences are consistent with perturbation
of the mitotic cell cycle. However, more subtle direct ef-
fects on interphase chromosome structure cannot be
excluded.
We next sought evidence of abnormal cell cycle progres-
sion in premalignant Caph2nes/nes cells from the relevant
developmental stage. DN thymocytes were purified from
young adults before tumor onset by fluorescence-activat-
ed cell sorting (FACS) and cultured on monolayers of
OP9-DL1 stromal cells (de Pooter and Zúñiga-Pflücker
2007), where they underwent extensive proliferation and
differentiated into DP cells. Caph2nes/nes thymocytes
showed impaired proliferation and differentiation in this
ex vivo system (Supplemental Fig. S4A,B), validating its
utility for mechanistic studies.
To address whethermitotic entry was delayed in prima-
ry Caph2nes/nes thymocytes, we used a BrdU chase assay
to follow the kinetics of progression from S phase into
Mphase (Fig. 3A). BrdU and nocodazolewere added simul-
taneously to day 5OP9/DL1 cultures in order to label cells
in S phase and arrest cells in prometaphase, respectively.
Over a 4-h time course, we then used flow cytometry to
measure the fraction of BrdU-labeled cells in mitosis
based on expression of the mitotic marker histone H3
phosphorylated at Ser10 (pH3S10). Caph2 mutation did
not affect the rate at which BrdU-labeled cells accumulat-
ed in mitosis (two-tailed t-test, P > 0.1 for all time points)
(Fig. 3B).
To determine whether cell cycle progression was im-
paired after mitotic entry, immunofluorescence was per-
formed on thymocytes grown on OP9-DL1 cocultures in
the absence of nocodazole using antibodies against α-tu-
bulin and pH3S10, and the proportion of pH3S10+ cells
at different stages of mitosis was assessed. Cells at later
stages (late anaphase and telophase) were significantly un-
derrepresented relative to earlier stages in the Caph2nes/
nesmutant cultures (Fisher’s exact, P < 0.003) (Fig. 3C), in-
dicating a cell cycle block that impaired progression into
successful anaphase. To enrich for anaphase cells, primary
Caph2nes/nes thymocytes from OP9/DL1 cocultures were
released into anaphase following washout of the protea-
some inhibitor MG132. Immunofluorescence revealed
an elevated frequency of abnormalities (Fisher’s exact, P
Figure 2. Caph2 mutation accelerates
T-cell clonal outgrowth in a P53-dependent
manner. Pie charts show the frequency of
the five most abundant TCRβ clones (gray
segments) in the thymuses of animals of dif-
ferent genotypes at 3-wk post-partum rela-
tive to the remainder of clones detected in
each sample (white segment). The percent-
ageofthetoptwoclonesineachsampleislist-
ed at the right of each chart. Data for P53
single-mutantanimalswerepublishedprevi-
ously (Dudgeon et al. 2014) and reanalyzed
through the ImmunoSeq Analyzer portal on
theAdaptive BiotechnologiesWeb site.
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< 0.0001), primarily comprising anaphase bridges plus oc-
casional lagging chromosomes, multipolar spindles, and
micronuclei (Fig. 3D,E). These mitotic abnormalities are
likely to originate from defective mitotic chromosome
structure because metaphase chromosomes showed a
characteristic “zig-zag” appearance following hypotonic
treatment (Fig. 3F), similar to previous reports of conden-
sin II deficiency in immortalized vertebrate cells (Ono
et al. 2003; Green et al. 2012). Abnormalmitosis had a pro-
found effect on the ploidy of proliferating DP thymocytes,
with an accumulation of cells with a DNA content of 4N
or greater (Supplemental Fig. S4C). Importantly, T cells
with abnormal ploidy were already abundant in neonatal
Caph2nes/nes mice (Supplemental Fig. S4C) substantially
before clonal expansion is first detectable (Fig. 2). The pro-
found mitotic abnormalities evident in Caph2nes/nes T
cells therefore precedemalignant transformation and can-
not be a downstream consequence.
Given that mitosis is thought to be a cell type-invariant
process, we next sought to determine whether ploidy
is perturbed to a similar extent in all cell types of
Caph2nes/nes mice. Multiparametric flow cytometry was
used to compare cellular DNA content as hematopoietic
stem and early progenitor cells fromCaph2nes/nes and con-
trol animals differentiate into αβ-T and B lymphocytes in
vivo (Fig. 4; Supplemental Figs. S5, S6). This revealed that
ploidy was largely unaffected by Caph2mutation in bone
marrow progenitor populations, B cells, and early thymic
T-cell subsets, with abnormalities becoming evident only
from the β-selection stage of T-cell development onwards
(Fig. 4; Supplemental Fig. S5). This cell type-specific phe-
notypewas not simply attributable to a greater proportion
of proliferating cells because BrdU incorporation was de-
tected in a comparable percentage of DP CD71+ T cells
(61%) (Supplemental Fig. S5H) and B cells at the fraction
C stage (59%) (Supplemental Fig. S5D) in wild-type
Figure 3. Tumor-causingCaph2mutations impairmitotic progression. (A) Overview of the BrdU chase experiment to assess the progres-
sion of primary CD4+CD8+ thymocytes from S phase into M phase. (B) Line graph showing the accumulation of BrdU+ cells in M phase
(pH3S10+) over a 4-h time course, as described in A. Error bars show SEM of two biological replicates and are representative of two inde-
pendent experiments. (C ) Mitotic phase distribution of unsynchronized H3S10P+ thymocytes fromwild-type (blue) andCaph2nes/nes (red)
OP9-DL1 cocultures stained with anti-H3S10P, anti-α-tubulin, and DAPI. Cells staining positive for the mitotic marker H3S10P were vi-
sually assigned to one of three mitotic phase categories. Data were pooled from two biological replicate experiments. n = 59 mitotic cells
for Caph2+/+; n = 111 for Caph2nes/nes. (∗) P < 0.003, two-tailed Fisher’s exact. (D) Examples of anaphase/telophase cells following MG132
washout inCaph2nes/nesOP9/DL1 cocultures, costained for α-tubulin (green), H3S10P (red), andDAPI (blue). For clarity, tubulin staining is
shown in only themultipolar spindle image. Bars, 3 µm. (E) The percentage of normal and abnormal anaphase/telophaseT cells fromOP9/
DL1 cocultures 1 h following MG132 washout for wild type and the Caph2mutant. Data represent one experiment. (F ) Structured illu-
minationmicroscopy (SIM) images of DAPI-stainedmetaphase chromosomes fromwild-type (top) andCaph2nes/nes (bottom) cells. Images
are representative of >30 metaphase spreads from three independent experiments.
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mice, yet abnormal ploidy inCaph2mutants was restrict-
ed to T cells (Fig. 4).
Together, these data demonstrate that germline hypo-
morphic mutation in Caph2 impairs cell cycle pro-
gression at a specific stage of αβ-T-cell development;
CD4+CD8+ thymocytes enter mitosis with normal kinet-
ics but abnormal chromosome structure, which leads to
anaphase bridges and impairedmitotic progression in pre-
malignant cells, preceding tumor initiation. Moreover,
our studies of hematopoietic differentiation demonstrate
that the samemutation in condensin II can elicit different
effects on chromosome segregation in different pro-
liferative cell types, which suggests that the formation
of segregation-competent mitotic chromosomes is a
developmentally regulated process.
Exit fromCaph2-deficient mitosis leads to DNA damage,
tetraploidy, and P53 activation
Using imaging flow cytometry, we next assessed the inci-
dence of DNA damage in primary thymocytes at different
phases of the cell cycle by the simultaneous quantifica-
tion of γH2AX foci, BrdU incorporation, andDNAcontent
(Fig. 5A–C). In the smallest 25% of cells with 2N DNA
content, which includes cells that have recently complet-
ed mitosis, γH2AX foci occurred in 85% of Caph2nes/nes,
compared with just 2% of wild-type cells (Supplemental
Fig. S7). The average number of discrete γH2AX foci per
nucleus was also significantly increased by Caph2 muta-
tion (Fig. 5C; Supplemental Fig. S7B). However, elevated
frequencies of cells with γH2AX foci were also observed
in S and G2 phase (Fig. 5B), which could be explained by
defective DNA repair or the ongoing acquisition of dam-
age during S phase.
In addition to diploid cells withDNA damage, we found
an abundance of abnormally largeDP cells that had under-
gone cell cycle arrest (Fig. 6A,B). Quantification of DNA
content in this population revealed that they were 4N
(Fig. 6C), suggesting arrest either during G2 or in a tetra-
ploid G1 phase. However, given that Caph2nes/nes thymo-
cytes progress from S phase to M phase with normal
kinetics (Fig. 3B), we hypothesized that a tetraploid G1
was themore likely scenario. To confirm this, we assessed
sister chromatid cohesion in FACS-purified 4N cells using
FISH experiments that combined fosmid probes and chro-
mosome paints (Fig. 6D). This revealed that, contrary to
the expectation for a G2 cell, the four chromosomal ho-
mologs were typically not subject to sister chromatid co-
hesion (Fig. 6D,E). We therefore conclude that these
arrested 4N cells, which make up at least 20% of all
CD4+CD8+ cells in the Caph2nes/nes thymus (Fig. 6A,B),
are arrested in a tetraploid cell cycle phase resembling
G1, presumably following mitotic exit without complet-
ing chromosome segregation and cytokinesis.
P53-dependent checkpoints ordinarily limit the prolif-
eration of cells with DNA damage (Kastan et al. 1991;
Lowe et al. 1993) and abnormal ploidy (Fujiwara et al.
2005; Thompson and Compton 2010) and play a key role
in suppressing lymphomagenesis in bothwild-type (Done-
hower et al. 1992) and Caph2nes/nes animals (Figs. 1C, 2).
To interrogate the signaling pathways operating down-
stream from P53 in Caph2nes/nes thymocytes, we assessed
the expression of 84 known P53 targets by quantitative
RT–PCR (qRT–PCR) in noncycling (CD71−) DP cell popu-
lations isolated from young animals prior to tumor estab-
lishment. Key regulators of apoptosis (Noxa and Fas) and
cell cycle arrest (Cdkn1a) were up-regulated by >2.5-fold
in Caph2nes/nes thymocytes in a P53-dependent manner
(Supplemental Fig. S8A; Supplemental Table S3). Nota-
bly, we found that the up-regulation of P53 targets oc-
curred in cells with 2N as well as 4N DNA content
(Supplemental Fig. S8B), demonstrating that P53 signaling
is activated regardless of whether cells exit mitosis in a
diploid or tetraploid state.
Figure 4. Mitoticperturbationarisesspecif-
ically in the tumor-initiating cell population.
Flow cytometry histograms show cellular
DNA content profiles during differentiation
of T and B lymphocytes from multipotent
progenitors in vivo. Tissues were harvested
at 6–8 wk, before tumors are first detected.
The tumor-initiating cell population (DP
CD71+) is highlighted with a red box. Gates
representthe4Nand>4Npopulations,which
are quantified here for the tumor-initiating
cell population and for all B-cell and T-cell
subsetsinSupplementalFigureS5.B-cellsub-
sets were classified into Hardy fractions A–F
(Hardy et al. 1991). Gating schemes used to
identifyeachpopulationareshowninSupple-
mental Figure S6, and cell surface markers
andantibodies are listed inSupplementalTa-
bles S5 and S6, respectively. Each histogram
represents at least 2000 cells and is represen-
tativeofthreebiologicalreplicatesforprogen-
itor subsets and five biological replicates for
T-cell and B-cell subsets.
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P53 status determines copy number changes in Caph2
mutant tumors
To characterize genomic changes that accompany lym-
phomagenesis in Caph2 mutant T cells, we performed
shallow whole-genome sequencing (Scheinin et al. 2014)
of genomic DNA extracted from terminal tumors of ani-
mals with germline mutation in Caph2 and P53 (Fig. 7;
Supplemental Fig. S9). Whole-chromosome aneuploidy
(WCA) was rare in terminal tumors fromCaph2nes/nes sin-
gle mutants (n = 7 tumors; mean WCA= 1.4; median
WCA = 1) (Fig. 7B). Absolute copy number enumeration
of selected loci by FISH (Supplemental Fig. S10) confirmed
that Caph2nes/nes single-mutant tumors were near diploid
rather than tetraploid. Although deletions spanning the
P53 locus were not apparent in Caph2nes/nes single-mu-
tant lymphomas, several top-scoring deletions encom-
passed key P53 pathway components such as Cdkn2a
and Pten and other known suppressors of human T-cell
malignancy such as Bcl11b (Supplemental Table S4; Gu-
tierrez et al. 2011). Thus, despite the abundance of tetra-
ploid cells in the premalignant DP population (Figs. 4, 6;
Supplemental Fig. S4C), these data argue that tumors
from Caph2nes/nes; P53+/+ mice initiate from cells that ac-
quire DNA damage and mutation without undergoing ge-
nome doubling (Fig. 5; Supplemental Fig. S7).
Tumors from double-mutant animals contained signifi-
cantly more WCAs than Caph2nes/nes single mutants (n =
13 tumors; meanWCA= 7.3; medianWCA= 6; two-tailed
t-test P < 0.001) (Fig. 7B; Supplemental Fig. S9). Double-
mutant tumors also contained, on average, twofold to
threefold more segmental copy number aberrations
(CNAs) compared with Caph2 single-mutant tumors
and >25-fold more than tail DNA (Fig. 7C,D). Recurrently
amplified regions contained known oncogenic drivers of
human malignancy, including Notch (12 of 13 tumors)
and Smyd2 (11 of 13 tumors). We conclude that the large
population of cells with abnormal ploidy, which is present
in the Caph2nes/nes thymus before clonal expansion, has
the potential to form highly aggressive tumors but is ordi-
narily prevented from doing so by a P53-dependent
mechanism.
Discussion
In this study, we provide experimental support for the hy-
pothesis that condensin dysfunction can promote tumor-
igenesis (Ham et al. 2007; Longworth et al. 2008; Coschi
et al. 2010, 2014; Manning et al. 2010; Hirano 2012). We
found that tumors initiate from thymic T cells pro-
gressing from the DN to DP stage, which allowed us to
characterize the cellular abnormalities that precede and
therefore presumably drive Caph2-dependent malignan-
cy. Through detailed cytological analysis of tumor-initiat-
ing cells in the thymuses of Caph2nes/nes mice, we show
that a tumor-causing mutation in Caph2 does not pro-
mote global decondensation of interphase chromatin
Figure 5. Widespread DNA damage in Caph2 mu-
tant thymocytes. (A) Multispectral images showing
representative thymocytes from different cell cycle
stages, classified based on DNA content and BrdU in-
corporation. Images were acquired on an Image-
Stream flow cytometer using a 60× objective. (B)
Histogram showing the percentage of cells with at
least one bright γH2AX focus at different cell cycle
stages. (C ) Histogram showing the frequency of
γH2AX foci per nucleus across all cell cycle stages.
For B and C, error bars show SEM of n = 3 biological
replicate experiments, each comprising 10,000 cells
per sample.
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(Supplemental Fig. S2) or major changes in developmental
gene expression programs (Supplemental Fig. S3). Howev-
er, we leave open the possibility that the Caph2nes muta-
tion impairs interphase processes in a manner that was
not detected in our study.
Abundant evidence was obtained for a direct effect of
theCaph2nesmutation onmitosis. Tumor-initiating cells
at the DP CD71+ stage of T-cell differentiation show im-
paired mitotic progression, but not mitotic entry (Fig. 3),
and generate two distinctly abnormal cell populations
upon mitotic exit. Diploid cells show extensive DNA
damage (Fig. 5; Supplemental Fig. S7), and we propose
that when such damage yields mutations in tumor sup-
pressor genes such as Cdkn2a, Pten, or Bcl11b (Supple-
mental Table S4), this population can give rise to the
near diploid lymphomas observed in aging Caph2nes/nes
animals (Fig. 7A; Supplemental Figs. S9, S10). In addition,
a large fraction (>20%) of all DP thymocytes in young
Caph2 mutants exits mitosis in a tetraploid state (Fig.
6B,C).
The fact that tumors in Caph2nes/nes animals with an
intact P53 pathway do not show frequent whole-chromo-
some gains argues that tetraploidy does not promote
malignancy in the presence of P53, consistent with previ-
ous reports (Fujiwara et al. 2005). Under these circum-
stances, we speculate that mitotic exit in the tetraploid
state may be a more favorable outcome for cells with
persistent catenations than completion of chromosome
segregation with DNA damage because the latter has
greater potential to generate oncogenic mutations.
Disease progression is markedly accelerated when the
P53 pathway is disabled (Fig. 1C), where abnormal clonal
outgrowth is readily detectable by deep sequencing of the
TCRβ repertoire during the first 3 wk of life (Fig. 2). In a
Caph2nes/nes P53−/− background, dominant clones exhibit
multiple whole-chromosome gains (Fig. 7A; Supplemen-
tal Fig. S9D) or evidence of genome doubling (Supplemen-
tal Fig. S9D). The high fraction of viable tetraploid cells
that arise spontaneously in the Caph2nes/nes thymus
(Fig. 6), combined with the rapid and highly reproducible
course of disease progression in Caph2nes/nes P53−/− ani-
mals (Figs. 1C, 2), provides an attractive model for future
studies on the pathological consequences of genome dou-
bling in vivo.
In a companion study, we describe a cohort of four hu-
man patients with germline condensin mutations that re-
sult in microcephalic primordial dwarfism (Martin et al.
2016). One of these patients died frommalignant anaplas-
tic medulloblastoma at the age of 11, which suggests that
germline condensin deficiency may increase the risk of
tumorigenesis in humans. Somatic condensin mutations
occur in a small but statistically significant fraction of hu-
man cancers (4.2%) (Leiserson et al. 2015), and a large ma-
jority of condensin mutations in the COSMIC database
(http://cancer.sanger.ac.uk/cosmic) comprises missense
substitutions analogous to Caph2nes (Fig. 1B; Supplemen-
tal Fig. S1A). However, genomic analyses of human T-cell
leukemias and lymphomas (Zhang et al. 2012; Kataoka
et al. 2015) indicate that condensin mutations are no
more frequent than in other tumor types, suggesting
that the strong tissue selectivity reported here is likely
to be species-specific. The reasons that murine T-cell de-
velopment is uniquely vulnerable to global condensin II
mutation are likely to be multifaceted but could involve
kinetic properties of the cell cycle or stress responses aris-
ing from aberrant mitosis that distinguish the highly pro-
liferative cells at the DN-to-DP transition from other
somatic cell types.
Several recent reports have provided evidence that con-
densin II function could be impaired in human tumors via
Figure 6. Genome doubling causes cell cycle exit in
Caph2mutant thymocytes. (A) Flow cytometry contour
plots (gated on CD4+CD8+ thymocytes from 6-wk to 12-
wk animals) showing a substantial increase in the pro-
portion of abnormally large (FSChi) nonproliferating
(BrdU−) cells in Caph2nes/nes animals. Percentages repre-
sent mean values from three biological replicates. (B)
Contour plots are presented as in A, with proliferation
status measured by cell surface expression of CD71.
Gates that define populations 1–4 in C are shown in
red. Percentages represent mean values from three bio-
logical replicates. (C ) DNA content of populations 1–4
from B, determined by flow cytometry quantification of
DAPI fluorescence. The noncycling population that is
greatly expanded in the Caph2nes/nes mutant thymus
(FSChiCD71lo) is exclusively 4N. Data are representative
of five biological replicates. (D) FISH analysis of FACS-
purified nonproliferating large thymocytes (populations
2 and 4 in B) using a chromosome 2 (Chr2) exome paint
(red) and a probe (green) corresponding to theHoxD locus
(HoxD) on chromosome 2. Two paired fosmid signals per
nucleus are visible in population 2, whereas population 4
has four individual signals per nucleus, indicating the ab-
sence of sister chromatid cohesion. Bar, 4 μm. (E) Quantification of spatially separated (>0.5 µm)HoxD signals is depicted in the histogram.
Data were pooled from two biological replicates. n = 81 Caph2+/+; n = 68 Caph2nes/nes.
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a more widespread mechanism that does not require mu-
tations in the core complex (Longworth et al. 2008; Coschi
et al. 2010, 2014; Manning et al. 2010). Mutations in the
Rb tumor suppressor, which is among themost frequently
mutated genes in a broad range of human tumors, partially
impair condensin II loading and function (Longworth et al.
2008; Coschi et al. 2010, 2014; Manning et al. 2010). This
provides a possible explanation for the high levels of chro-
mosomal instability reported in Rb1-deficient tumors
and, together with the data reported here, suggests that
the clinical relevance of this alternative Rb1 function
should be carefully evaluated.
Materials and methods
Animals and primary cell isolation
The animal studies described here were carried out under the
guidance issued by theMedical Research Council in Responsibil-
ity in the Use of Animals for Medical Research (July 1993) and
Home Office Project License no PPL60/4424. Animals were
housed in individually ventilated cages within the Biomedical
Research Facility at the Western General Hospital, Edinburgh.
Tumor samples from Caph2+/+; P53−/− tumors used for copy
number analysis were from animals housed in the Biological Ser-
vices Unit facilities at the Cancer Research UK Beatson Institute
under project license PPL60/4181. The Caph2nes (Nelms and
Goodnow 2001; Gosling et al. 2007) and P53− (Jacks et al. 1994)
mutations were generated as described previously and main-
tained on a C57BL6/J background. Unless otherwise stated, non-
tumor tissues were harvested from 6- to 12-wk animals and
processed immediately. No differences in T-cell phenotype
were observed between male and female mice; hence, animals
of either gender were used interchangeably. Female mice were
used for all aging studies, with the exception of the Caph2nes/
nes P53−/− genotype, for which males were used due to a low fre-
quency of female mice recovered.
Single-cell suspensionswere obtained from thymuses by gentle
tissue dissociation through a 40-µm filter and from femurs and
tibias by flushing bone cavities with PBS (B cells) or crushing
bones with a pestle and mortar (LSK and CLP populations). Tis-
sues were collected and processed immediately following termi-
nation, and cell counts were conducted on a Moxi-Z automated
cell counter (Orflo). For BrdU incorporation studies, 150 µL of
10 mg/mL BrdU solution was injected into the intraperitoneal
cavity 2 h prior to termination.
Cell culture
For primary T-cell cultures, CD4+ andCD8+ thymocytes were de-
pleted using MACS beads (Miltenyi) according to the manufac-
turer’s instructions. For the proliferation and differentiation
assays shown in Supplemental Figure S4 and the mitotic studies
shown in Figure 3, DN3 cells were then purified by FACS using
Figure 7. P53 status determines the fre-
quency of WCA and segmental aneuploidy
in Caph2 mutant tumors. (A) Example
copy number aberration (CNA) plots
showing read depth from shallowwhole-ge-
nome sequencing of Caph2nes/nes; P53+/+,
Caph2+/+; P53−/−, and Caph2nes/nes; P53−/−
double-mutant tumors. Copy number gains
are shown in red, and deletions are shown
in blue. Additional plots are shown in Sup-
plemental Figure S9. (B) Frequency of
WCAs based on shallow whole-genome se-
quencing in tumors arising on the indicated
genotypes and control DNA from aged (9–
15 mo) Caph2nes/nes tail. Red bars indicate
the mean. Error bars show SEM. Brackets
above the plot link conditions for which
two-tailed t-tests gave significant P-values
(<0.001). (C ) Frequency of CNAs ≥1 Mb,
presented as in B. Error bars link conditions
for which two-tailed t-tests gave significant
P-values (<0.03). (D) Frequency of CNAs
≥30 kb, presented as in B. Error bars link
conditions for which two-tailed t-tests
gave significant P-values (<0.05).
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surface expression of CD25 and CD44. For the BrdU chase exper-
iment in Figure 3, A and B, total DN cells were seeded, whereas,
for all other OP9/DL1 experiments of mitosis and cell cycle pro-
gression, DN3 cells were seeded directly following FACS purifica-
tion. Details of cell surface marker combinations used for
immunophenotyping are in Supplemental Table S5. DN cells
(1 × 105 to 5 × 105 cells) or DN3 cells (2.5 × 104 cells) were seeded
onto each well of a six-well plate containing subconfluent mono-
layers of OP9-DL1 stromal cells in α-MEM medium (+nucleo-
sides) supplemented with 20% fetal bovine serum, 1%
penicillin/streptomycin, 15 µM β-mercaptoethanol, and 1 ng/
mL IL-7 (Peprotech). Cell cycle studies were conducted 4 or 5 d af-
ter seeding total DNcells, when lymphocyteswere removed from
monolayers by gentle pipetting and then passed through a 40-µm
filter to remove clumps of stromal cells before further processing.
For BrdU chase experiments, 10 µM BrdU (final concentration)
and 300 ng/mL nocodazole were added to cultures on day 4 or
5, and cells were collected at the specified time points before
staining for cell surface markers pH3S10 and BrdU using the
APC BrdU Flow kit (BD Pharmingen) according to the manufac-
turer’s instructions, with pH3S10 antibody added at the same
time as anti-BrdU.
Immunofluorescence
Cells from OP9-DL1 cocultures were washed once with PBS and
allowed to settle on polylysine-coated coverslips. For MG132 re-
lease, MG132 (Cayman) was added to day 4 OP9/DL1 cocultures
to a final concentration of 15 µM. After 2 h, T cells were removed
by gentle pipetting, washed once with PBS, and seeded on fresh
OP9-DL1 monolayers in medium lacking MG132. After 60 min,
T cells were removed by gentle pipetting and allowed to settle
on polylysine-coated coverslips. Cells were fixed in 4% parafor-
maldehyde for 10 min, washed three times for 5 min in PBS (re-
ferred to here as “washed”), permeabilized in 0.5% Triton X in
PBS for 10 min, washed, blocked in goat or donkey serum (5%
in PBS) for 30 min, incubated with primary antibodies overnight
at 4°C, washed, incubated with secondary antibodies for 1 h at
room temperature, washed, incubated in 0.5 µg/mL DAPI for 5
min, and thenmounted in VectaShield (Vector Laboratories). An-
tibodies used in this study are in Supplemental Table S6.
Metaphase spreads
Togeneratemetaphase spreads, cellswere treatedwith hypotonic
solution (0.5% sodium citrate, 0.25% potassium chloride in de-
ionized water) and fixed in 3:1 methanol:acetic acid added drop-
wise while vortexing the sample. The samples were incubated
for 30min at room temperature before centrifugation, resuspend-
ed in 10mL of fix, and stored overnight at−20°C. The cell suspen-
sion was dropped onto high-precision coverglass (Marienfelt),
stained with 50 ng/mL DAPI in PBS, and mounted in Prolong
Gold (Life Technologies). Three-dimensional structured illumi-
nation microscopy (SIM) images were acquired on a N-SIM
(Nikon Instruments) using a 100× 1.49 NA lens and refractive in-
dex-matched immersion oil (Nikon Instruments). SIM images
were reconstructed using NiS Elements software (Nikon Instru-
ments) from a z-stack comprised of no less than 1 µm of optical
sections.
FISH probe synthesis, hybridization, and image analysis
To prepare nuclei for three-dimensional FISH, cells were allowed
to settle on polylysine-coated slides, fixed in 4% PFA for 10 min
at 37°C, washed, permeablized in 0.5% Triton X in PBS for 10
min, washed, and left to dehydrate at room temperature before
being stored for up to 2 mo at −80°C. Upon thawing, slides
were rinsed in 2× SSC and then incubated in 2× SSC containing
100 µg/mL RNase (Roche) for 1 h at 37°C. Slides were washed in
2× SSC and then dehydrated through a series of 2-min ethanol
washes (70%, 90%, and 100%) before being air-dried. Slides
were then heated for 5 min in a 70°C oven and denatured for
30 min at 80°C in 70% formamide/2× SSC (pH 7.5). The slides
were transferred to ice-cold 70% EtOH for 2 min before further
dehydration in 90% and 100% ethanol for 2 min each at room
temperature.
With the exception of the experiment presented in Figure 5 (see
below), all FISH probes were generated from fosmids (details in
Supplemental Table S7). To prepare fosmid probes, DNAwas iso-
lated using standard alkaline lysis and labeled by nick translation
with digoxigenin-11-dUTP or biotin-16-dUTP (Roche). Approxi-
mately 70–100 ng of fosmid was used per slide, together with
18 µg of mouse Cot1 (Invitrogen) DNA and 5 µg of salmon sperm
DNA (Sigma). Ethanol-precipitated DNA was resuspended in 15
µL of hybridizationmix (50% deionized formamide, 10% dextran
sulfate, 1% Tween 200 in 2× SSC). Probes were denatured for 5
min at 70°C and then reannealed at 37°C before being applied
to the slide and sealed under a coverslip at 37°C. After 48 h, cov-
erslips were removed, and slides underwent four 2-min washes in
2× SSC at 45°C and then four 3-min washes in 0.1× SSC at 60°C.
Slides were then transferred to 4× SSC/0.1%Tween at room tem-
perature before a 5-min incubation with blocking buffer (4× SSC,
5%Marvel) under a coverslip. Biotinylated probes were detected
using 1 mg/mL Texas Red (TR)-conjugated avidin stock diluted
1:500 in blocking buffer followed by 0.5 mg/µL biotinylated anti-
avidin (BAA) diluted 1:100 and a final layer of 1 mg/mL TR-con-
jugated avidin diluted 1:500. Digoxigenin-labeled probes were
detected with sequential layers of 200 µg/mL fluorsecein isothio-
cyanate (FITC)-conjugated anti-digoxigenin diluted 1:20 and 1.5
mg/mL FITC-conjugated anti-sheep diluted 1:100. All antibodies
were obtained from Vector Laboratories with the exception of
FITC-conjugated anti-digoxigenin, which was obtained from
Roche. Antibody incubations were carried out in a humid cham-
ber for 30–60 min at 37°C followed by three 2-min washes in 4×
SSC/0.1% Tween at 37°C before the addition of the next layer
of antibody. After the last antibody incubation, slides were incu-
bated in 4× SSC/0.1% Tween with 50 ng/mL DAPI for 2 min be-
fore mounting in VectaShield (Vector Laboratories).
For the experiment to assess sister chromatid cohesion present-
ed in Figure 6, D and E, both the chromosome 2 exome paint and
130-kb HoxD-specific probe were generated by direct labeling of
liquid-phase oligonucleotide pools obtained using sequence cap-
ture technology (Boyle et al. 2011). The oligonucleotide isolation,
labeling, and hybridization stepswere performed as described pre-
viously (Boyle et al. 2011). To assess sister chromatid cohesion,
we FACS-purified 4N cells and counted the number of distinct
HoxD signals per nucleus. For quantification purposes, only sig-
nals separated by >0.5 µm were counted. Probes generated from
oligonucleotide pools (Fig. 6D,E) lacked repetitive sequences,
and hence false positive signals were greatly reduced.
Flow cytometry, FACS, and imaging flow cytometry
Single-cell suspensions were incubated with antibodies against
cell surface antigens for 10 min at room temperature and washed
once in PBS prior to analysis. The combination of cell surface
markers used to identify each cell population is in Supplemental
Table S5, with antibody details in Supplemental Table S6. For
DNA content analysis, surface stains were fixed using the Cyto-
Fix/CytoPerm kit (BD) according to the manufacturer’s instruc-
tions before a secondary fixation step in cold 70% ethanol for
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20min at 4°C and awash in cytopermbuffer (BD Pharmingen) be-
fore resuspension in cytoperm buffer containing 10 µg/mL DAPI.
Datawere acquired on a BD FACSAria II cell sorter or BD LSRFor-
tessa cell analyzer and processed using FlowJo software (TreeS-
tar). DNA content measurements by flow cytometry were
susceptible to artifacts arising from cell aggregates. For all con-
ventional flow cytometry experiments, we performed strict ag-
gregate exclusion based on area versus height of the DAPI and
forward scatter signals (data not shown). We also validated our
finding of elevated polyploidy inCaph2nes/nes cells using imaging
flow cytometry and FISH (data not shown).
BrdU staining was performed using the APC BrdU Flow kit (BD
Pharmingen) according to the manufacturer’s instructions. For
quantification of γH2AX-positive cells at different cell cycle stag-
es, total thymocytes were isolated from the thymuses of mice 2 h
following BrdU injection and stained with anti-BrdU-APC, anti-
γH2Ax-FITC, and DAPI using the BrdU Flow kit protocol (BD
Pharmingen). Fluorescent and bright-field images were captured
using an ISxMKII (Amnis) using a 60× objective. Following acqui-
sition and compensation, the data were analyzed with IDEAS
(Amnis) software using a modified version of published methods
(Parris et al. 2015) as follows. In addition to the automatically gen-
erated system image masks, three further masks were built. The
first mask eroded the DAPImask by two pixels to ensure that any
perinuclear signal was not included in subsequent analysis of nu-
clear staining patterns and intensities. A second mask was gener-
ated based on FITC intensity, removing pixels with an intensity
of ≤600 to remove background and nonspecific staining and en-
sure that only clearly defined intense spots were retained for
counting. A third mask used a Boolean instruction to combine
the two masks described above to ensure that only FITC foci lo-
calized to the region of the nuclei were counted. A spot count fea-
ture was generated based on the combined mask.
A data analysis pathway identified round single cells (RSCs) on
the basis of size and circularity of the bright-field images. Gated
RSCs were input into a histogram to select cells in focus based
on the intensity of adjacent pixels in an image (the gradient
root mean squared function). In-focus RSCs were then used as
the population in a histogram to identify BrdU-positive and
BrdU-negative cells. Cells that were 2N and ≥4N were identified
from the BrdU-negative population based on DAPI fluorescence.
The three populations were plotted by number of γH2AX foci
against overall γH2AX staining intensity (e), and cells with at
least one focus above an intensity threshold were categorized as
γH2AX-positive.
TCR sequencing
DNA was extracted from flash-frozen thymus tissue using
DNeasy blood and tissue kit (Qiagen). The TCRβ locus was se-
quenced using the ImmunoSeq assay (Adaptive Biotechnologies)
at survey-level resolution using 0.8–1 µg of startingmaterial. PCR
amplicons spanning the variable to constant sections of the TCRβ
chainwere sequenced using the IlluminaMiSeq platform, and po-
tential PCR biases were controlled using algorithms provided by
Adaptive Biotechnologies (Carlson et al. 2013). Data were ana-
lyzed using the ImmunoSeq data analysis portal on the Adaptive
Biotechnologies Web site. The two samples from P53−/− single
mutants were from a published study (Dudgeon et al. 2014), the
data for which were available through the ImmunoSeq portal
for analysis alongside the data generated for this study.
Copy number data generation
Genomic DNAwas isolated from FFPE tumor samples using the
BioStic FFPE kit (Mo Bio Laboratories) and from flash-frozen tu-
mor samples using theDNAeasy kit (Qiagen). Copy number anal-
ysis was performed as described previously (Scheinin et al. 2014).
In brief, DNAwas shearedwith aCovaris S2 (Covaris) followed by
theTruSeqNANOkit version 2 (Illumina). Final sequence library
amplification was performedwith 10 PCR cycles for the FFPE-de-
rived DNA samples and eight PCR cycles for DNA derived from
fresh samples. Theyield of the sequence librarywas assessedwith
a DNA 7500 chip on a 2100 BioAnalyzer (Agilent Technologies).
A double-sided bead size selection procedure with Agencourt
AMPure XP beads (Beckman Coultier) was performed to clean
the DNA preparations. The barcoded mouse samples were equi-
molarly pooled, and 12.5 pM molarity with 1% ϕX was loaded
onto a HiSeq Single-End FlowCell (Illumina). This was followed
by cluster generation on a cBot (Illumina) and sequencing on a
HiSeq 2500 (Illumina) in single-read 50-cycle run mode (SR50-
HTV4). Sequence data are available from the Sequence Read Ar-
chive under project accession SRP065379.
Copy number data analysis
Themouse reference version GRCm38/mm10 was used to deter-
mine GC content and mappability. GC content was calculated
for 30-kb and 1-Mb bin sizes, and mappability was determined
with GEM mappability (Derrien et al. 2012) allowing two mis-
matches. Loess residuals, used tomake amouse C57BL/6J-specif-
ic blacklist, were calculated with 24 samples obtained from a
publicly available normal mouse C57BL/6J data set (Gnerre
et al. 2011). Only the first 50 base pairs (bp) of the forward read
were included for residual calculation. In addition, the 50-bp
reads of the three normal mouse C57BL/6J samples, sequenced
in parallel with the tumors, were included in the residual calcula-
tions. The data were analyzed with QDNAseq version 1.4.2
(Scheinin et al. 2014). Copy number profiles were segmented
with DNAcopy (Venkatraman and Olshen 2007), and CNAs
were called by selecting segments with a log2 ratio >0.20 or lower
than −0.23, corresponding to a single gain or a single loss in 30%
of the analyzed cells (van Thuijl et al. 2014). Breakpoints were
defined at the junction between bins of different copy number ac-
cording to the criteria above. For the deletion list in Supplemental
Table S4, we started with all regions of copy number loss in
Caph2nes/nes single-mutant tumor samples and removed regions
corresponding to the X chromosome and TCR loci in addition
to regions also deleted in Caph2nes/nes tail DNA. The remaining
regions were ranked according to log2 ratio, and the top 10
ranking regionsweremanually curated to identify tumor suppres-
sor genes.
Homology detection and structural interpretation
of mutation
The mouse Caph2 sequence was used to search for homologous
structures using the HHPred server (Söding et al. 2005). Three
bacterial condensin structure hits (Protein Data Band IDs
4I98_A, 3ZGX_C, and 3W6J_A) were returned with their corre-
sponding alignment that included the first two α helices. Addi-
tional Caph2 vertebrate orthologs were detected with a BLAST
search against the SwissProt database at the NPS@ server (Com-
bet 2000) and included into the multiple sequence alignment
withminor manual editing. Figure 1B was prepared using ESPript
version 3 (Gouet et al. 2003). Intraprotein interactions for the
I15N equivalent residue in Bacillus subtilis (I22) were analyzed
using the protein interactions calculator (PIC) (Tina et al. 2007)
using a 5 Å sphere radius cutoff. Residue-specific solvent accessi-
bility calculations were performed using ASAView (Ahmad et al.
2004). Structure visualization and analysis and the preparation of
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Figure 1B were conducted using PyMOL (http://www.pymol.org;
Schrödinger LLC).
Transcriptome analysis
Total RNA was extracted using TRIzol reagent (Life technolo-
gies), and RNA quality was assessed using Bioanalyzer (Agilent).
From each of three biological replicates per sample (cell purifica-
tion scheme detailed in Supplemental Fig. S3A), 80 ng of RNA
was amplified and biotinylated using the MessageAmp II kit
(Ambion). cRNA (750 ng) was hybridized to mouse Ref-8 version
2 Expression Beadchips (Illumina) using a whole-genome expres-
sion direct hybridization kit (Illumina) and scanned with a High-
scan (Illumina). Raw data were analyzed using Bioconductor with
the FlexArray software package (http://genomequebec.mcgill.ca/
FlexArray). RMA background adjustment, variance stabilization
transformation (VST), and robust spline normalization were ap-
plied. Mean signal values were calculated at the gene level using
ANOVA, and tests for difference between sample types were con-
ducted using equal variance t-tests. Using conventional cutoffs
for statistical significance (>twofold change, P < 0.05), very few
transcripts were returned as differentially expressed between
stage-matched DP thymocyte populations. To identify more
subtle trends, all genes on the array with associated Ensembl
and gene symbol annotations were first ranked according to fold
change (Caph2nes/nes/Caph2+/+), and the ranked list was used as
the input for gene ontology term enrichment within the “pro-
cess” classification using the GOrilla tool (http://cbl-gorilla.cs.
technion.ac.il). Full lists of terms returned by the GOrilla tool
are in Supplemental Tables S1, S2, and S8. MIAME-compliant
microarray data are available under Gene Expression Omnibus
accession number GSE65199.
qRT–PCR
For the qPCR array experiments depicted in Supplemental Figure
S8A and Supplemental Table S3, DP CD71− cells were purified
from thymocytes that were first enriched for CD4+ cells by
MACS (miltenyi) and then FACS purified for CD4+, CD8+, and
CD71+ using the scheme outlined in Supplemental Figure S6C.
Cell purity was typically 85%–95%. Total RNA was extracted
from cells using TRIzol reagent (Life technologies) followed by
purification through an RNAeasy colum (Qiagen). RNA quality
was assessed using Bioanalyzer (Agilent). From each of two bio-
logical replicates per sample, 100 ng of RNA was reverse-tran-
scribed using the RT2 first strand kit (Qiagen). qRT–PCR was
performed on technical quadruplicates using the mouse P53
pathway qRT–PCR array (Qiagen, PAMM-027Z). Normalization
and all downstream analysis steps were performed according to
themanufacturer’s instructions, and data analysis was conducted
using the RT2 profiler PCR array software (Qiagen). For the exper-
iment in Supplemental Figure S8B, total thymocytes were incu-
bated with Hoechst for 30 min in Hank’s balanced salts
solution, sorted according to DNA content, and processed as
above using primers designed in house. All qRT–PCR data in Sup-
plemental Figure S8, A and B, and Supplemental Table S3 repre-
sent mean values from two biological replicate experiments,
each comprising two technical replicate PCRs.
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